Author

Serdar Gayybov

Rosalind Franklin University of Medicine and Science

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Na Li· 1 shared Qi‐En WangiD· 1 shared Weihang ChaiiD· 1 shared Zubair Ahmed LaghariiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Na Li

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNAR CancerPeer-reviewedJul 27, 2026

STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation

Zubair Ahmed Laghari, Na Li, Serdar Gayybov…·Weihang Chai

This study identifies STN1 as a factor promoting PARPi resistance in BRCA2-deficient cancer cells by stabilizing replication forks and reducing ssDNA gaps.

DOI 10.1093/narcan/zcag023

humanbulk RNA-seq

𝕏 PostBluesky